FDA Says Inspections Continue as Government Shutdown Drags On

The FDA’s crucial responsibility to inspect and investigate the various pharmaceutical facilities it regulates will continue despite the US government moving toward the fourth week of a shutdown, according to an agency official.

“I want to assure you that our inspectional focus continues,” Elizabeth Miller, acting deputy associate commissioner for inspections and investigations at the Food and Drug Administration, said Monday at a conference focused on generic and biosimilar drugs.

“Carryover user fee funding enables us to conduct the most FDA inspections that directly impact your industry,” Miller said when discussing the current appropriations environment. “Additionally, the FDA continues non-fee ...